| Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options JCO Sardi, L Scorzoni, T Bernardi, AM Fusco-Almeida, ... Journal of medical microbiology 62 (1), 10-24, 2013 | 1492 | 2013 |
| Molecular typing of IberoAmerican Cryptococcus neoformans isolates W Meyer, A Castañeda, S Jackson, M Huynh, E Castañeda, ... Emerging infectious diseases 9 (2), 189, 2003 | 700 | 2003 |
| Antifungal therapy: new advances in the understanding and treatment of mycosis L Scorzoni, ACA de Paula e Silva, CM Marcos, PA Assato, ... Frontiers in microbiology 8, 242257, 2017 | 422 | 2017 |
| Glyceraldehyde-3-Phosphate Dehydrogenase of Paracoccidioides brasiliensis Is a Cell Surface Protein Involved in Fungal Adhesion to Extracellular Matrix … MS Barbosa, SN Báo, PF Andreotti, FP de Faria, MSS Felipe, ... Infection and immunity 74 (1), 382-389, 2006 | 232 | 2006 |
| Highlights in pathogenic fungal biofilms. MGMJ Sardi Jde C, Pitangui Nde S, Rodríguez-Arellanes G Rev Iberoam Micol. 31 (1), 22-9, 2014 | 214* | 2014 |
| Imbalance of IL-2, IFN-γ and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis G Benard, CC Romano, CR Cacere, M Juvenale, MJS Mendes-Giannini, ... Cytokine 13 (4), 248-252, 2001 | 209 | 2001 |
| Fungal biofilms and polymicrobial diseases CB Costa-Orlandi, JCO Sardi, NS Pitangui, HC De Oliveira, L Scorzoni, ... Journal of Fungi 3 (2), 22, 2017 | 201 | 2017 |
| Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment FP Gullo, SA Rossi, JCO Sardi, VLI Teodoro, MJS Mendes-Giannini, ... European journal of clinical microbiology & infectious diseases 32, 1377-1391, 2013 | 159 | 2013 |
| Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile L Scorzoni, MP de Lucas, AC Mesa-Arango, AM Fusco-Almeida, ... PloS one 8 (3), e60047, 2013 | 158 | 2013 |
| The use of standard methodology for determination of antifungal activity of natural products against medical yeasts Candida sp and Cryptococcus sp L Scorzoni, T Benaducci, AMF Almeida, DHS Silva, VS Bolzani, ... Brazilian Journal of Microbiology 38, 391-397, 2007 | 144 | 2007 |
| Comparative study of disk diffusion and microdilution methods for evaluation of antifungal activity of natural compounds against medical yeasts Candida spp and Cryptococcus sp L Scorzoni, T Benaducci, A Almeida, DHS Silva, VS Bolzani, ... | 139 | 2007 |
| In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms CB Costa-Orlandi, JCO Sardi, CT Santos, AM Fusco-Almeida, ... Biofouling 30 (6), 719-727, 2014 | 138 | 2014 |
| Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst FS LEITE, L SCORZONI, AC MESA-ARAGANO, C CASAS, E HERRERO, ... Microbes and Infection 13, 457-467, 2011 | 135 | 2011 |
| Detection of the 43,000-molecular-weight glycoprotein in sera of patients with paracoccidioidomycosis MJ Mendes-Giannini, JP Bueno, MA Shikanai-Yasuda, AW Ferreira, ... Journal of clinical microbiology 27 (12), 2842-2845, 1989 | 135 | 1989 |
| A New Fibrin Sealant From Crotalus durissus terrificus Venom: Applications in Medicine LC Barros, RS Ferreira Jr, S Barraviera, HO Stolf, IA Thomazini-Santos, ... Journal of Toxicology and Environmental Health, Part B 12 (8), 553-571, 2009 | 130 | 2009 |
| Pathogenesis II: fungal responses to host responses: interaction of host cells with fungi MJS Mendes-Giannini, ML Taylor, JB Bouchara, E Burger, VLG Calich, ... Medical Mycology 38 (sup1), 113-123, 2000 | 129 | 2000 |
| New antimicrobial therapies used against fungi present in subgingival sites—a brief review JCO Sardi, AMF Almeida, MJSM Giannini Archives of oral biology 56 (10), 951-959, 2011 | 118 | 2011 |
| Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options JCO Sardi, DR Silva, MJS Mendes-Giannini, PL Rosalen Microbial pathogenesis 125, 116-121, 2018 | 117 | 2018 |
| Analysis of the Paracoccidioides brasiliensis triosephosphate isomerase suggests the potential for adhesin function LA Pereira, SN Báo, MS Barbosa, JLM Da Silva, MSS Felipe, ... FEMS yeast research 7 (8), 1381-1388, 2007 | 115 | 2007 |
| Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? AR Voltan, G Quindos, KPM Alarcón, AM Fusco-Almeida, ... International Journal of Nanomedicine, 3715-3730, 2016 | 105 | 2016 |
Luis Octavio RegasiniProfessor of Medicinal Chemistry - Laboratory of Antibiotics and Chemotherapeutics - IBILCE - UNESPE-mail confirmado em unesp.br
